Form 8-K - Current report:
SEC Accession No. 0001104659-21-082673
Filing Date
2021-06-17
Accepted
2021-06-17 16:55:02
Documents
14
Period of Report
2021-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120013d1_8k.htm   iXBRL 8-K 37565
2 EXHIBIT 99.1 tm2120013d1_ex99-1.htm EX-99.1 15213
6 GRAPHIC tm2120013d1_ex99-1img001.jpg GRAPHIC 2996
  Complete submission text file 0001104659-21-082673.txt   240064

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20210616.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20210616_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20210616_pre.xml EX-101.PRE 22711
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2120013d1_8k_htm.xml XML 3606
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 211025444
SIC: 2834 Pharmaceutical Preparations